CML Advocates Network co-founders receive the 2022 iCMLf Prize
During the month of March 2022, the International CML Foundation announced the iCMLf Prizes for 2022. These prestigious global awards are conferred on individuals who have played a major role in advancing the understanding and management of CML.
On this ocassion, Giora Sharf and Jan Geissler, chronic myeloid leukemia (CML) patient advocates and co-founders of the CML Advocates Network, have been awarded the 2022 iCMLf Prize for their achievements in the field of patient advocacy using the experience of their own diagnosis to help other patients across the world.
Apply for an EHA 2022 Fellowship until 17th April
The European Hematology Association (EHA) has already opened the Fellowship Application and Registration process by providing 100 Full registration fellowships for leaders of hematology patient organisations.
This year, EHA is organizing its first hybrid EHA22 Congress in Vienna, Austria, and again providing patient advocates the opportunity to attend the conference both in-person and virtually from June 9 to 17.
If you are a representative of a CML patient organisation interested in attending this Congress, you have the possibility to apply for an EHA Fellowship and attend the 27th EHA Congress HERE.
Calling CML patients living in Ukraine
CML Advocates Network stands in solidarity with the CML patients in Ukraine.
CML Advocates Network statement supporting fellow members and patients in Ukraine.
The CML Advocates Network is an active network specifically for leaders of Chronic Myeloid Leukemia (CML) patient groups, connecting 128 patient organisations in 93 countries on all continents. It was set-up and is run by CML patients
In the light of recent geopolitical events in Ukraine we fully support our members and patients and families living with CML.
Following the recent COVID-19 pandemic during which care for so many patients living with cancer has undeniably suffered it is unfortunate that the recent series of events has ocurred and will certainly prolong the effects on those living with cancer and with CML in Ukraine.
As a patient-led global organisation it has always been our belief that disease has no borders and we have always working together both within CML and with the wider patient community to advance the voice of those who have been touched by disease and their families in order to highlight its effect on society.
We stand by our fellow members and patients in Ukraine and with wider global community in asking for common sense and diplomacy to prevail so that normal people living their lives can continue as such and in particular those who find themselves living with cancer and in our case CML can access the care and treatment that they fundamentally need.
As CML Advocates Network we stand by our members and their families and the wider medical community affected during these times.
ASH 2021 CML Conference Report
The 63rd ASH Annual Meeting and Exposition organised by the American Society of Hematology was presented at the Georgia World Congress Center in Atlanta, Georgia – and virtually – from December 11-14, 2021.
We have prepared a Conference Report in order to provide you the latest updates on the management of chronic myeloid leukemia and the most important highlights presented in this key meeting for the CML community.
Download the ASH 2021 Conference report by clicking on the image below:
Celia Marín - Head of Communications - celia@cmladvocates.net
EBMT 48th Annual Meeting and Patient, Family and Donor Day
The European Society for Blood and Marrow Transplantation is a collaborative peer network of professionals working, in centres and as individuals, in the field of clinical bone marrow transplantation and cellular therapy.
Every year, they hold the Annual Meeting as the most important event for research and education in the field of bone marrow transplantation and cellular therapy in Europe.
We are proud to announce that our Abstract titled “Chronic Myeloid Leukemia Access To Tyrosine Kinase Inhibitors And Polymerase Chain Reaction Testing. A Patient Advocacy Perspective From Central-Eastern Europe And West Asia Region. Jelena Čugurović, Šarūnas Narbutas, Jana Pelouchová, Denis Costello, Celia Marin.” has been accepted for poster presentation at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2022) to be held as a hybrid event in Prague, Czech Republic from the 19th to the 23rd of March 2022.
